Literature DB >> 8462082

Epicardial and subselective transcoronary chemical ablation of incessant ventricular tachycardia.

S Gursoy1, P Nellens, G Guiraudon, J Brugada, P Brugada.   

Abstract

Incessant ventricular tachycardia in patients with severely depressed ventricular function remains a major therapeutic challenge. Although alcohol ablation via the tachycardia related vessel has been shown to be an effective alternative, it might not be applicable in some cases due to anatomic limitations. In three patients with ischemic cardiomyopathy and incessant ventricular tachycardia no effective antiarrhythmic therapy could be found. Alcohol ablation was then attempted but the tachycardia related vessel could not be intubated. A subselective injection of alcohol into a more proximal segment of the coronary artery was then performed in two cases. In one patient as subselective injection was also not possible, the injection was performed epicardially after thoracotomy. Ablation was successful in all cases. In very selected cases of incessant ventricular tachycardia that have failed all other therapeutic interventions, alcohol ablation of the tachycardia can be performed using an epicardial or subselective transcoronary injection of alcohol.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462082     DOI: 10.1002/ccd.1810280410

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  3 in total

1.  Cryoablation of incessant ventricular tachycardia: case report and long-term follow-up.

Authors:  H Afshar; A Rasekh; B Treistman; C Van Leeuwen; J M Duncan; A Massumi
Journal:  Tex Heart Inst J       Date:  2000

2.  Epicardial ablation as a bailout in electrical storm?

Authors:  Ghaliah Al Mohani; Carsten Israel; Michela Casella; Corrado Carbucicchio
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-06-19

3.  Incessant ventricular tachycardia acutely controlled with off-pump coronary artery bypass surgery and aneurysmal plication.

Authors:  Alireza Heydari; Asadollah Mirzaie; Mohammad Tayyebi
Journal:  J Tehran Heart Cent       Date:  2010-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.